1 |
林丽琳, 王承党. 粪钙卫蛋白在炎症性肠病中的应用价值[J]. 胃肠病学, 2019, 24(4): 247-250.
|
2 |
吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813.
|
3 |
GAJENDRAN M, LOGANATHAN P, CATINELLA A P, et al. A comprehensive review and update on Crohn's disease[J]. Dis Mon, 2018, 64(2): 20-57.
|
4 |
CHEN Y. Perspectives of IBD China: is Crohn's and colitis foundation model a solution to health care issues for the country? [J]. Inflamm Bowel Dis, 2018, 24(5): 925-929.
|
5 |
RIMOLA J, ORDÁS I, RODRIGUEZ S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity[J]. Inflamm Bowel Dis, 2011, 17(8): 1759-1768.
|
6 |
POUS-SERRANO S, FRASSON M, PALASÍ GIMÉNEZ R, et al. Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn's disease of the small bowel[J]. Colorectal Dis, 2017, 19(5): O126-O133.
|
7 |
MOOIWEER E, FIDDER H H, SIERSEMA P D, et al. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation[J]. Inflamm Bowel Dis, 2014, 20(2): 307-314.
|
8 |
POUS-SERRANO S, FRASSON M, CERRILLO E, et al. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease[J]. J Surg Res, 2017, 213: 290-297.
|
9 |
曾俊祥, 吕婕, 罗婷, 等. 粪便钙卫蛋白检测及其实验影响因素[J]. 临床检验杂志, 2019, 37(10): 756-759.
|
10 |
MA C, BATTAT R, KHANNA R, et al. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?[J]. Best Pract Res Clin Gastroenterol, 2019, 38/39: 101602.
|
11 |
NIKOLAUS S, WAETZIG G H, BUTZIN S, et al. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases[J]. Int J Colorectal Dis, 2018, 33(7): 927-936.
|
12 |
马智聪. 白介素-6和白介素-2受体与克罗恩病活动性的关系[J]. 临床合理用药杂志, 2018, 11(2): 173-174.
|
13 |
陈丹, 陈洋, 李骥, 等. 血清IL-6与TNF-α在克罗恩病疾病评估中的应用[J]. 胃肠病学和肝病学杂志, 2020, 29(3): 279-284.
|